High-temperature high-entropy alloy with light weight and high strength in as-cast state and preparation method thereof
US-2024410035-A1 · Dec 12, 2024 · US
US2021198779A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2021198779-A1 |
| Application number | US-202117197633-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 10, 2021 |
| Priority date | Nov 22, 2017 |
| Publication date | Jul 1, 2021 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to the use of a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy, characterized in that it comprises from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with said alloy being capable of forming a single-phase material consisting of a stable and homogeneous a solid solution of Hexagonal Close Packed (HCP) structure at room temperature in the medical, transport or energy fields.
Opening claim text (preview).
1 .- 12 . (canceled) 13 . A product comprising or consisting in a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy comprising from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with the alloy being capable of forming a single-phase material consisting of a stable and homogeneous α solid solution with a Hexagonal Close Packed (HCP) structure at room temperature. 14 . The product according to claim 13 wherein the product is a medical device. 15 . The product according to claim 13 wherein the product is a medical device, said medical device being a dental implant. 16 . The product according to claim 13 wherein the product is a medical device, said medical device being an orthopedic implant. 17 . The product according to claim 13 wherein the product is a component for medical applications or dental applications. 18 . The product according to claim 13 wherein the product is a component for aerospace applications, nuclear applications, energy applications, chemical processing applications or transportation applications. 19 . A method of utilizing a product in aerospace applications, nuclear applications, energy applications, chemical processing applications, medical applications, dental applications or transportation applications, said product comprising or consisting in a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy comprising from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with the alloy being capable of forming a single-phase material consisting of a stable and homogeneous a solid solution with a Hexagonal Close Packed (HCP) structure at room temperature. 20 . A method according to claim 19 , wherein the product is a dental implant or an orthopedic implant, and wherein the method comprises implanting said dental implant or said orthopedic implant to a subject in need thereof. 21 . A ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy comprising from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with the alloy being capable of forming a single-phase material consisting of a stable and homogeneous α solid solution with a Hexagonal Close Packed (HCP) structure at room temperature, said alloy being in the form of a powder. 22 . A process for preparing a product comprising or consisting in a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy comprising from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with the alloy being capable of forming a single-phase material consisting of a stable and homogeneous α solid solution with a Hexagonal Close Packed (HCP) structure at room temperature, wherein the process comprises the following steps: providing a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy comprising from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with the alloy being capable of forming a single-phase material consisting of a stable and homogeneous α solid solution with a Hexagonal Close Packed (HCP) structure at room temperature, said alloy being in powder form or in massive form, processing said alloy, to obtain said product. 23 . The process according to claim 22 , wherein the ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy is in the form of a powder. 24 . The process according to claim 22 , wherein the ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy is in the form of an ingot, a bar, a wire, a tube, a sheet or a plate. 25 . The process according to claim 22 wherein the product is a medical device. 26 . The process according to claim 22 wherein the product is a medical device, said medical device being a dental implant. 27 . The process according to claim 22 wherein the product is a medical device, said medical device being an orthopedic implant. 28 . The process according to claim 22 , wherein the step of processing is performed by thermomechanical processing. 29 . The process according to claim 22 , wherein the step of processing is performed by thermomechanical processing, wherein the thermomechanical processing is cold-working.
Related publications grouped by family.
Answers are generated from the same data shown on this page.